Cancer is the leading cause of death in Canada. Although new treatments are evolving, early detection is still the key to improving survival rates. Physicians need access to the most advanced early detection and screening strategies so they can treat patients as promptly as possible.
As Canada Research Chair in Precision Cancer Diagnostics and Artificial Intelligence, Dr. Jesse Chao aims to develop artificial intelligence-based precision medicine technologies for early cancer screening. To do this, he and his research team are assessing genetic predisposition to hereditary cancers through clinical genetics and identifying potentially cancerous lesions through digital pathology. Their long-term goal is to help physicians accurately assess cancer risk and diagnose lesions.